Literature DB >> 11393822

Mutation rates in the dihydrofolate reductase gene of Plasmodium falciparum.

S Paget-McNicol1, A Saul.   

Abstract

A new method has been established to define the limits on a spontaneous mutation rate for a gene in Plasmodium falciparum. The method combines mathematical modelling and large-scale in vitro culturing and calculates the difference in mutant frequencies at 2 separate time-points. We measured the mutation rate at 2 positions in the dihydrofolate reductase (DHFR) gene of 3D7, a pyrimethamine-sensitive line of P. falciparum. This line was re-cloned and an effectively large population was treated with a selective pyrimethamine concentration of 40 nM. We detected point mutations at codon-46 (TTA to TCA) and codon-108 (AGC to AAC), resulting in serine replacing leucine and asparagine replacing serine respectively in the corresponding gene product. The substitutions caused a decrease in pyrimethamine sensitivity. By mathematical modelling we determined that the mutation rate at a given position in DHFR was low and occurred at less than 2.5 x 10(-9) mutations/DHFR gene/replication. This result has important implications for Plasmodium genetic diversity and antimalarial drug therapy by demonstrating that even with low mutation rates anti-malarial resistance will inevitably arise when mutant alleles are selected under drug pressure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11393822     DOI: 10.1017/s0031182001007739

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  34 in total

Review 1.  How can we identify parasite genes that underlie antimalarial drug resistance?

Authors:  Tim Anderson; Standwell Nkhoma; Andrea Ecker; David Fidock
Journal:  Pharmacogenomics       Date:  2011-01       Impact factor: 2.533

2.  Plasmodium falciparum strains harboring dihydrofolate reductase with the I164L mutation are absent in Malawi and Zambia even under antifolate drug pressure.

Authors:  Edwin Ochong; David J Bell; David J Johnson; Umberto D'Alessandro; Modest Mulenga; Sant Muangnoicharoen; Jean-Pierre Van Geertruyden; Peter A Winstanley; Patrick G Bray; Stephen A Ward; Andrew Owen
Journal:  Antimicrob Agents Chemother       Date:  2008-08-25       Impact factor: 5.191

3.  Plasmodium falciparum and dihydrofolate reductase I164L mutations in Africa.

Authors:  Alisa P Alker; Jonathan J Juliano; Steven R Meshnick; Andrew Owen; Edwin Ochong; David J Bell; David J Johnson; Umberto d'Alessandro; Modest Mulenga; Sant Muangnoicharoen; J P Van Geertruyden; Peter A Winstanley; Patrick G Bray; Stephen A Ward
Journal:  Antimicrob Agents Chemother       Date:  2009-04       Impact factor: 5.191

4.  Independent evolution of pyrimethamine resistance in Plasmodium falciparum isolates in Melanesia.

Authors:  Toshihiro Mita; Kazuyuki Tanabe; Nobuyuki Takahashi; Takahiro Tsukahara; Hideaki Eto; Lek Dysoley; Hiroshi Ohmae; Kiyoshi Kita; Srivicha Krudsood; Sornchai Looareesuwan; Akira Kaneko; Anders Björkman; Takatoshi Kobayakawa
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

5.  Plasmodium falciparum infection dynamics and transmission potential following treatment with sulfadoxine-pyrimethamine.

Authors:  Michelle L Gatton; Qin Cheng
Journal:  J Antimicrob Chemother       Date:  2006-04-26       Impact factor: 5.790

6.  The de novo selection of drug-resistant malaria parasites.

Authors:  N J White; W Pongtavornpinyo
Journal:  Proc Biol Sci       Date:  2003-03-07       Impact factor: 5.349

7.  Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents.

Authors:  David J Johnson; David A Fidock; Mathirut Mungthin; Viswanathan Lakshmanan; Amar Bir Singh Sidhu; Patrick G Bray; Stephen A Ward
Journal:  Mol Cell       Date:  2004-09-24       Impact factor: 17.970

8.  Probability of emergence of antimalarial resistance in different stages of the parasite life cycle.

Authors:  Wirichada Pongtavornpinyo; Ian M Hastings; Arjen Dondorp; Lisa J White; Richard J Maude; Sompob Saralamba; Nicholas P Day; Nicholas J White; Maciej F Boni
Journal:  Evol Appl       Date:  2009-02       Impact factor: 5.183

9.  Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty.

Authors:  David L Smith; Eili Y Klein; F Ellis McKenzie; Ramanan Laxminarayan
Journal:  Malar J       Date:  2010-07-23       Impact factor: 2.979

10.  Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria.

Authors:  Corine Karema; Mallika Imwong; Caterina I Fanello; Kasia Stepniewska; Aline Uwimana; Supatchara Nakeesathit; Arjen Dondorp; Nicholas P Day; Nicholas J White
Journal:  Antimicrob Agents Chemother       Date:  2009-10-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.